Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-729-9 | CAS number: 87-19-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Eye irritation
Administrative data
- Endpoint:
- eye irritation: in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 19.04.-12.05.2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 017
- Report date:
- 2017
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 492 (Reconstructed Human Cornea-like Epithelium (RhCE) Test Method for Identifying Chemicals Not Requiring Classification and Labelling for Eye Irritation or Serious Eye Damage)
- Version / remarks:
- July, 2015
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Hessisches Ministerium für Umwelt, Klimaschutz, Landwirtschaft und Verbraucherschutz, Mainzer Strasse 80, 65189 Wiesbaden, Germany
Test material
- Reference substance name:
- Isobutyl salicylate
- EC Number:
- 201-729-9
- EC Name:
- Isobutyl salicylate
- Cas Number:
- 87-19-4
- Molecular formula:
- C11H14O3
- IUPAC Name:
- 2-methylpropyl 2-hydroxybenzoate
Constituent 1
Test animals / tissue source
- Species:
- human
- Strain:
- other: not applicable
- Details on test animals or tissues and environmental conditions:
- - EpiOcular Kit: MatTek Corporation (82105 Bratislava, Slovakia) normal, human-derived epidermal keratinocytes which have been cultured to form a stratified squamous epithelium similar to that found in the human cornea.
- Surface: 0.6 cm
- Shipment: at 2 - 8 °C on medium-supplemented agarose gels
- Equilibration step: 15 minutes at room temperature
- Inspection: each tissue was inspected for air bubbles between the agarose gel and insert. Cultures with air bubbles under the insert covering greater than 50% of the insert area were not used.
- Pre-incubation: standard culture conditions for 1 hour and after refreshing the Assay Medium at standard culture conditions overnight (nearly 17 hours)
Test system
- Vehicle:
- unchanged (no vehicle)
- Controls:
- yes, concurrent positive control
- yes, concurrent negative control
- Amount / concentration applied:
- 50 μL for the test item (undiluted) and the controls
- Duration of treatment / exposure:
- 30 minutes
- Duration of post- treatment incubation (in vitro):
- 120 minutes at 37 ± 1.5 °C in a humidified atmosphere of 5 ± 0.5% CO2
- Number of animals or in vitro replicates:
- 2 replicates (two tissues)
- Details on study design:
- Details of the test procedure:
- conditions of exposure: 37 ± 1.5 °C, 5 ± 0.5% CO2, 95% RH
- rinsing the tissues with Ca++Mg++-free DPBS
- MTT assay:
-- After post-treatment incubation of 120 minutes the MTT assay was performed
-- 0.3 mL of MTT solution
-- incubated for 180 minutes at standard culture conditions
-- in 2.0 mL of isopropanol stored overnight at 2-8 °C in the dark (17 hours) and then shaken for 2.5 hours at room temperature
-- The absorbance at 570 nm (OD570) of each well was measured with a plate reader (Versamax® Molecular Devices, 85737 Ismaning, Germany, Software Softmax Pro, version 4.7.1)
-- No reference wavelength measurement was used
Data evaluation:
1) The mean OD value of the blank control wells (ODBlk) for each experiment was calculated.
2) The mean value of the two replicates for each tissue was calculated.
3) The mean ODBlk from each mean OD value of the same experiment was subtracted (blank
corrected values).
4) The mean value of the two relating tissues for each control (negative control (NC) and
positive control (PC) and test item (TI) was calculated (ODTI, ODNC, ODPC).
5) The mean OD value of the negative control corresponds to 100% viability.
Corrected negative control OD = Negative Control OD - ODBlk = 100% Viability
Calculations for Viability Tests only:
1) The percent viability of each of the two relating tissues for each control and test item relative to the negative control (= 100%) was calculated. Viability (%) = 100 x (OD TI OD PC / OD NC) / meanOD NC
2) The difference of the viability between duplicate tissues was calculated. If the difference is >20% the test is considered as non-qualified.
3) The mean test item viability (TI viability) was calculated and the test item was classified according to the prediction model
Prediction Model:
If the test item-treated tissue viability is > 60% relative to the negative control treated tissue viability, the test item is labeled non-irritant.
If the test item-treated tissue viability is ≤ 60% relative to negative control treated tissue viability, the test item is labeled irritant.
A single test composed of at least two tissue replicates should be sufficient for a test chemical, when the result is unequivocal.
However, in cases of borderline results, such as non-concordant replicate measurements and/or mean percent tissue viability equal to 60±5%,
a second test should be considered, as well as a third one in case of discordant results between the first two tests.
Acceptability of the Assay:
The results are acceptable according to MatTek Protocol, if:
1) The negative control OD is > 0.8 and < 2.5,
2) The mean relative viability of the positive control is below 50% of the negative control viability.
3) The difference of viability between the two relating tissues of a single test item is < 20% in the same run (for positive and negative control tissues and tissues of test items).
This applies also to the freeze-killed tissues (items and negative control) and the additional viable tissues (without MTT addition) which are calculated as percent values related to the viability of the relating negative control.
Results and discussion
In vitro
Results
- Irritation parameter:
- other: mean relative cell viability (%)
- Run / experiment:
- mean of two tissues
- Value:
- 75.9
- Vehicle controls validity:
- valid
- Negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Remarks on result:
- no indication of irritation
- Other effects / acceptance of results:
- Treatment with the positive control induced a decrease in the mean relative absorbance compared with the negative control to 20.6%, thus the validity of the test system is ensured.
In vivo
- Other effects:
- The main experiment was performed twice. Since in the 1st main experiment the acceptance criteria were not met, a 2nd main experiment was performed. Only the results of the 2nd main experiment are reported.
Any other information on results incl. tables
Results after treatment for 30 minutes with the test item and the controls
Dose Group | Absorbance Well 1 (Tissue 1/2) | Absorbance Well 2 (Tissue 1/2) | Mean absorbance* (Tissue 1/2) | Mean Absorbance* Tissue 1 and 2 | Mean absorbance of 2 Tissues* | Rel. Absorbance (%) Tissue 1 and 2** | Absolute Value of the Difference of the Rel. Absorbances (%) Tissue 1 and 2 | Mean Rel Absorbance (% of Negative Control)** |
Blank | 0.038 | 0.038 | 0.038 | 0.000 | ||||
NC | 1.813 | 1.937 | 1.875 | 1.837 | 1.864 | 99.5 | 1.0 | 100.0 |
1.893 | 1.894 | 1.894 | 1.855 | 100.5 | ||||
PC | 0.424 | 0.453 | 0.439 | 0.401 | 0.379 | 21.7 | 2.3 | 20.6 |
0.395 | 0.398 | 0.396 | 0.358 | 19.4 | ||||
Test Item | 1.374 | 1.48 | 1.427 | 1.389 | 1.402 | 75.2 | 1.4 | 75.9 |
1.458 | 1.446 | 1.452 | 1.414 | 76.6 |
* Mean of two replicate wells after blank correction
** Relative absorbance [rounded values]: 100 x (absorbance test item / positive control) / (mean absorbance negative control)
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- In this study and under the experimental conditions reported, the test item does not possess any eye irritating potential.
- Executive summary:
This in vitro study was performed to assess the eye irritation potential of the test item by means of the Human Cornea Model Test. The study was performed in accordance to OECD TG 492 and in compliance to GLP.
The test item did not prove to be an MTT reducer in the MTT pre-test, and it did not prove to dye water or isopropanol in the colour interference pre-test. Therefore, additional tests with freeze-killed or viable tissues did not have to be performed.
Each 50 μL of the test item, the negative control (deionised water) or the positive control (methyl acetate) were applied to each of duplicate tissue for 30 minutes. After treatment with the negative control the absorbance values were well within the required acceptability criterion of OD > 0.8 and < 2.5 thus showing the quality of the tissues. Treatment with the positive control induced a decrease below 50% compared with the negative control value in the relative absorbance thus ensuring the validity of the test system. The difference of viability between the two relating tissues was < 20% in the same run (for test item tissues, positive and negative control tissues).
Irritating effects were not observed following incubation with the test item. Compared with the value of the negative control the relative mean absorption value corresponding to the viability of the tissues did not decrease below 60% (75.9%).
In conclusion, it can be stated that in this study and under the experimental conditions reported, the test item does not possess any eye irritating potential.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.